Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP Β/ζ signaling by menin

Oncogene

Volumn 29, Issue 39, 2010, Pages 5416-5426

  Feng, Z J ^a   Gao, S B ^a   Wu, Y ^a   Xu, X F ^b   Hua, X ^c   Jin, G H ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Second Hospital   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lung cancer; Men1; Migration; Pleiotrophin; RPTP

Indexed keywords

FOCAL ADHESION KINASE; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLEIOTROPHIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE BETA; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ZETA; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; CARRIER PROTEIN; CYTOKINE; MEN1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL; CELL MIGRATION; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; CELL MOTION; GENETICS; LUNG TUMOR; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARRIER PROTEINS; CELL MOVEMENT; CYTOKINES; HUMANS; INTEGRIN ALPHAVBETA3; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; SIGNAL TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASES;

MUS;

EID: 77957557698     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.282     Document Type: Article

References (42)

1. Baillat G, Siret C, Delamarre E, Luis J. (2008). Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raftdependent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta 1783: 2323-2331.
2. Carelli S, Zadra G, Vaira V, Falleni M, Bottiglieri L, Nosotti M et al. (2006). Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer 53: 263-271.
3. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR et al. (1997). Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-407.
4. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ et al. (2009a). Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res 39: 177-186.
5. Chen YJ, Wei YY, Chen HT, Fong YC, Hsu CJ, Tsai CH et al. (2009b). Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaBdependent pathway in human chondrosarcoma cells. J Cell Physiol 221: 98-108.
6. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA et al. (1997). Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6: 2285-2290.
7. Debelenko LV, Swalwell JI, Kelley MJ, Brambilla E, Manickam P, Baibakov G et al. (2000). MEN1 gene mutation analysis of highgrade neuroendocrine lung carcinoma. Genes Chromosomes Cancer 28: 58-65.
8. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. (2004). Integrins regulate Rac targeting by internalization of membrane domains. Science 303: 839-842.
9. Duces A, Karaky R, Martel-Renoir D, Mir L, Hamma-Kourbali Y, Bieche I et al. (2008). 16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development. Mol Cancer Ther 7: 2817-2827.
10. Gao SB, Feng ZJ, Xu B, Wu Y, Yin P, Yang Y et al. (2009). Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin. Oncogene 28: 4095-4104.
11. Gao SB, Hua X, Jin GH. (2008). Menin regulates endocrine diseases by controlling histone modification and gene transcription. Ann Endocrinol (Paris) 69: 426-432.
12. Hall A. (1998). Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
13. Hood JD, Cheresh DA. (2002). Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
14. Jager R, List B, Knabbe C, Souttou B, Raulais D, Zeiler T et al. (2002). Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Br J Cancer 86: 858-863.
15. Jin GH, Ma DY, Wu N, Marikar FM, Jin SZ, Jiang WW et al. (2007). Combination of human plasminogen kringle 5 with ionizing radiation significantly enhances the efficacy of antitumor effect. Int J Cancer 121: 2539-2546.
16. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y et al. (2005). Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102: 14659-14664.
17. Klein CA. (2008). Cancer. The metastasis cascade. Science 321: 1785-1787.
18. Lemos MC, Thakker RV. (2008). Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29: 22-32.
19. Liu G, Meng X, Jin Y, Bai J, Zhao Y, Cui X et al. (2008). Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biol Int 32: 663-670.
20. Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K et al. (2005). Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem 280: 26953-26964.
21. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. (2005). The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5: 505-515.
22. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, NodaM et al. (2000). Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 97: 2603-2608.
23. Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J et al. (2009). Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 101: 327-334.
24. Mikelis C, Sfaelou E, Koutsioumpa M, Kieffer N, Papadimitriou E. (2009). Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta. FASEB J 23: 1459-1469.
25. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. (2002). MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107-1117.
26. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y et al. (2005). Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102: 749-754.
27. Molloy T, van t Veer LJ. (2008). Recent advances in metastasis research. Curr Opin Genet Dev 18: 35-41.
28. Nelson WJ, Nusse R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487.
29. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG. (2004). Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science 303: 836-839.
30. Pannett AA, Thakker RV. (1999). Multiple endocrine neoplasia type 1. Endocr Relat Cancer 6: 449-473.
31. Pariser H, Ezquerra L, Herradon G, Perez-Pinera P, Deuel TF. (2005). Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem Biophys Res Commun 332: 664-669.
32. Pei XH, Bai F, Smith MD, Xiong Y. (2007). p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress nonsmall- cell lung cancers. Cancer Res 67: 3162-3170.
33. Perez-Pinera P, Chang Y, Deuel TF. (2007). Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts. Cell Cycle 6: 2877-2883.
34. Petzmann S, Ullmann R, Klemen H, Renner H, Popper HH. (2001). Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Hum Pathol 32: 333-338.
35. Polykratis A, Katsoris P, Courty J, Papadimitriou E. (2005). Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J Biol Chem 280: 22454-22461.
36. Schnepp RW, Chen YX, Wang H, Cash T, Silva A, Diehl JA et al. (2006). Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. Cancer Res 66: 5707-5715.
37. Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT et al. (2002). Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem 277: 35990-35998.
38. Tamura M, Gu J, Tran H, Yamada KM. (1999). PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91: 1820-1828.
39. von Wichert G, Jiang G, Kostic A, De Vos K, Sap J, Sheetz MP. (2003). RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin- cytoskeleton linkages. J Cell Biol 161: 143-153.
40. Weng T, Gao L, Bhaskaran M, Guo Y, Gou D, Narayanaperumal J et al. (2009). Pleiotrophin regulates lung epithelial cell proliferation and differentiation during fetal lung development via beta-catenin and Dlk1. J Biol Chem 284: 28021-28032.
41. Wu X, Hua X. (2008). Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective. Curr Mol Med 8: 805-815.
42. Yan J, Yang Y, Zhang H, King C, Kan HM, Cai Y et al. (2009). Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells. Oncogene 28: 973-982.